Management of factor Xa inhibitor–related traumatic non‐intracranial bleeding events with andexanet alfa or four‐factor prothrombin complex concentrate in a US multicenter observational study

Management of factor Xa inhibitor–related traumatic non‐intracranial bleeding events with andexanet alfa or four‐factor prothrombin complex concentrate in a US multicenter observational study

Abstract Objectives This study describes clinical characteristics and management strategies for patients with factor Xa (FXa) inhibitor–related traumatic non‐intracranial bleeds who were treated with andexanet alfa or four‐factor prothrombin complex concentrate (4F‐PCC). Methods An observational coh...

Full description

Bibliographic Details
Main Authors: Paul P. Dobesh, Craig I. Coleman, Mark Danese, Eva Lesén, Raymond C. Chang, Onivefu Odelade, Gregory J. Fermann
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Journal of the American College of Emergency Physicians Open
Subjects:
andexanet alfa
blood coagulation factor
factor Xa inhibitors
hemorrhage
injury
Online Access:https://doi.org/10.1002/emp2.13333

Internet

https://doi.org/10.1002/emp2.13333

Similar Items